Long-term treatment of acromegaly with bromocriptine.
- 2 April 1977
- Vol. 1 (6065) , 875-878
- https://doi.org/10.1136/bmj.1.6065.875
Abstract
Seventy-three patients with active acromegaly were treated for three to 25 months with bromocriptine 10-60 mg/day. Seventy-one patients showed symptomatic and objective clinical improvement. This included reduction in excessive sweating, hand and foot size, and the number of headaches; improved facial appearance; and increased energy and libido. Abnormal visual fields became normal in two patients, one of whom had concomitant radiotherapy. Mean circulating growth hormone levels, obtained by averaging serial samples through the day, fell by more than 7 microng/l or became undetectable in 58 patients (79%) but did not reach normal values: only 15 patients had mean levels on treatment of 5 microng/l or less. Twenty-three patients were diabetic before treatment, and glucose tolerance became normal in 15 and improved in a further five. Provided the drug was started slowly side effects were minor when compared with the considerable clinical benefit obtained.Keywords
This publication has 11 references indexed in Scilit:
- GASTROINTESTINAL BLEEDING IN PATIENTS ON BROMOCRIPTINEThe Lancet, 1976
- GASTROINTESTINAL BLEEDING IN PATIENTS ON BROMOCRIPTINEThe Lancet, 1976
- Digital Vasospasm with BromocriptineThe Lancet, 1976
- BROMOCRIPTINE THERAPY IN ACROMEGALYThe Lancet, 1975
- Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-?-ErgocryptineJournal of Clinical Endocrinology & Metabolism, 1975
- Bromocriptine treatment of acromegaly.BMJ, 1975
- Growth Hormone (GH)-Releasing Activity of TRH and GH-Lowering Effect of Dopaminergic Drugs in Acromegaly: Homogeneity in the Two ResponsesJournal of Clinical Endocrinology & Metabolism, 1974
- DECREASED PLASMA GROWTH HORMONE (GH) LEVELS IN ACROMEGALICS FOLLOWING CB 154(2-Br-α-ERGOCRYPTINE) ADMINISTRATION1Journal of Clinical Endocrinology & Metabolism, 1974
- Radioimmunoassay of human prolactin.1973
- Suppression of pituitary tumor growth and function by ergot alkaloids.1973